BACKGROUND: Perfluorinated compounds are ubiquitous pollutants; epidemiologic data suggest they may be associated with adverse health outcomes, including subfecundity. We examined subfecundity in relation to 2 perfluorinated compounds-perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA). METHODS: This case-control analysis included 910 women enrolled in the Norwegian Mother and Child Cohort Study in 2003 and 2004. Around gestational week 17, women reported their time to pregnancy and provided blood samples. Cases consisted of 416 women with a time to pregnancy greater than 12 months, considered subfecund. Plasma concentrations of perfluorinated compounds were analyzed using liquid chromatography-mass spectrometry. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for each pollutant quartile using logistic regression. Estimates were further stratified by parity. RESULTS: The median plasma concentration of PFOS was 13.0 ng/mL (interquartile range [IQR] = 10.3-16.6 ng/mL) and of PFOA was 2.2 ng/mL (IQR = 1.7-3.0 ng/mL). The relative odds of subfecundity among parous women was 2.1 (95% CI = 1.2-3.8) for the highest PFOS quartile and 2.1 (1.0-4.0) for the highest PFOA quartile. Among nulliparous women, the respective relative odds were 0.7 (0.4-1.3) and 0.5 (0.2-1.2). CONCLUSION: Previous studies suggest that the body burden of perfluorinated compounds decreases during pregnancy and lactation through transfer to the fetus and to breast milk. Afterward, the body burden may increase again. Among parous women, increased body burden may be due to a long interpregnancy interval rather than the cause of a long time to pregnancy. Therefore, data from nulliparous women may be more informative regarding toxic effects of perfluorinated compounds. Our results among nulliparous women did not support an association with subfecundity.
BACKGROUND:Perfluorinated compounds are ubiquitous pollutants; epidemiologic data suggest they may be associated with adverse health outcomes, including subfecundity. We examined subfecundity in relation to 2 perfluorinated compounds-perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA). METHODS: This case-control analysis included 910 women enrolled in the Norwegian Mother and Child Cohort Study in 2003 and 2004. Around gestational week 17, women reported their time to pregnancy and provided blood samples. Cases consisted of 416 women with a time to pregnancy greater than 12 months, considered subfecund. Plasma concentrations of perfluorinated compounds were analyzed using liquid chromatography-mass spectrometry. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for each pollutant quartile using logistic regression. Estimates were further stratified by parity. RESULTS: The median plasma concentration of PFOS was 13.0 ng/mL (interquartile range [IQR] = 10.3-16.6 ng/mL) and of PFOA was 2.2 ng/mL (IQR = 1.7-3.0 ng/mL). The relative odds of subfecundity among parous women was 2.1 (95% CI = 1.2-3.8) for the highest PFOS quartile and 2.1 (1.0-4.0) for the highest PFOA quartile. Among nulliparous women, the respective relative odds were 0.7 (0.4-1.3) and 0.5 (0.2-1.2). CONCLUSION: Previous studies suggest that the body burden of perfluorinated compounds decreases during pregnancy and lactation through transfer to the fetus and to breast milk. Afterward, the body burden may increase again. Among parous women, increased body burden may be due to a long interpregnancy interval rather than the cause of a long time to pregnancy. Therefore, data from nulliparous women may be more informative regarding toxic effects of perfluorinated compounds. Our results among nulliparous women did not support an association with subfecundity.
Authors: Cathrine Thomsen; Line S Haug; Hein Stigum; May Frøshaug; Sharon L Broadwell; Georg Becher Journal: Environ Sci Technol Date: 2010-11-23 Impact factor: 9.028
Authors: Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar Journal: Toxicol Sci Date: 2006-01-16 Impact factor: 4.849
Authors: Gerald L Kennedy; John L Butenhoff; Geary W Olsen; John C O'Connor; Andrew M Seacat; Roger G Perkins; Lisa B Biegel; Sandra R Murphy; David G Farrar Journal: Crit Rev Toxicol Date: 2004 Jul-Aug Impact factor: 5.635
Authors: Geary W Olsen; Jean M Burris; David J Ehresman; John W Froehlich; Andrew M Seacat; John L Butenhoff; Larry R Zobel Journal: Environ Health Perspect Date: 2007-09 Impact factor: 9.031
Authors: Kristina W Whitworth; Line S Haug; Azemira Sabaredzovic; Merete Eggesbo; Matthew P Longnecker Journal: Epidemiology Date: 2016-09 Impact factor: 4.822
Authors: Elise L Rush; Alison B Singer; Matthew P Longnecker; Line S Haug; Azemira Sabaredzovic; Elaine Symanski; Kristina W Whitworth Journal: Environ Int Date: 2017-12-20 Impact factor: 9.621
Authors: Emily S Barrett; Chongshu Chen; Sally W Thurston; Line Småstuen Haug; Azemira Sabaredzovic; Frøydis Nyborg Fjeldheim; Hanne Frydenberg; Susan F Lipson; Peter T Ellison; Inger Thune Journal: Fertil Steril Date: 2015-03-04 Impact factor: 7.329
Authors: Yan Wang; Lea A Cupul-Uicab; Walter J Rogan; Merete Eggesbo; Gregory Travlos; Ralph Wilson; Matthew P Longnecker Journal: J Phys Act Health Date: 2014-08-07
Authors: A L Brantsæter; K W Whitworth; T A Ydersbond; L S Haug; M Haugen; H K Knutsen; C Thomsen; H M Meltzer; G Becher; A Sabaredzovic; J A Hoppin; M Eggesbø; M P Longnecker Journal: Environ Int Date: 2013-02-15 Impact factor: 9.621
Authors: Germaine M Buck Louis; C Matthew Peterson; Zhen Chen; Mary L Hediger; Mary S Croughan; Rajeshwari Sundaram; Joseph B Stanford; Victor Y Fujimoto; Michael W Varner; Linda C Giudice; Anne Kennedy; Liping Sun; Qian Wu; Kurunthachalam Kannan Journal: Epidemiology Date: 2012-11 Impact factor: 4.822